CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Fluorouracil and Salicylic Acid

Last Updated: August 4, 2016
Result type: Reports
Project Number: SR0498-000
Product Line: Reimbursement Review

Generic Name: Fluorouracil and Salicylic Acid

Brand Name: Actikerall

Manufacturer: Cipher Pharmaceuticals Inc.

Therapeutic Area: Hyperkeratotic actinic keratosis

Indications: Hyperkeratotic actinic keratosis

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 22, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions